The modern approach should enhance new digital and electronic possibilities which weren’t given 50 years ago when the trade agreement was originally signed. With Switzerland being the UK’s 10^th largest trade partner the FTA should further boost their trade.  

For the pharmaceutical sector and the overall sector of life science, this step should further push the exchange of research and innovation topics. A Memorandum of Understanding signed in 2022 already covers cooperation in the field of science and technology. The Association of British Pharmaceutical Industry, ABPI welcomes the negotiations as “a pivotal opportunity for a world-leading agreement between two life science superpowers”.

Source:

UK government: Press release

ABPI: News